Abstract

Microbiome and paediatric gut diseases

Arch Dis Child. 2021 Oct 29;archdischild-2020-320875.doi: 10.1136/archdischild-2020-320875. Online ahead of print.

Konstantinos Gerasimidis 1, Konstantinos Gkikas 2, Christopher Stewart 3, Esther Neelis 4, Vaios Svolos 2

 
     

Author information

1Human Nutrition, University of Glasgow, Glasgow, UK konstantinos.gerasimidis@glasgow.ac.uk.

2Human Nutrition, University of Glasgow, Glasgow, UK.

3Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK.

4Paediatric Gastroenterology, Erasmus Medical Center-Sophia Children's Hospital, Rotterdam, The Netherlands.

Abstract

In the human gut resides a vast community of microorganisms which perform critical functions for the maintenance of whole body homeostasis. Changes in the composition and function of this community, termed microbiome, are believed to provoke disease onset, including non-communicable diseases. In this review, we debate the current evidence on the role of the gut microbiome in the pathogenesis, outcomes and management of paediatric gut disease. We conclude that even though the gut microbiome is altered in paediatric inflammatory bowel disease, coeliac disease, intestinal failure, necrotising enterocolitis and irritable bowel syndrome, there are currently very few implications for unravelling disease pathogenesis or guiding clinical practice. In the future, the gut microbiome may aid in disease differential diagnosis and prediction of clinical outcomes, and comprise a target for therapeutic interventions.

© Copyright 2013-2022 GI Health Foundation. All rights reserved.
This site is maintained as an educational resource for US healthcare providers only. Use of this website is governed by the GIHF terms of use and privacy statement.